FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称ZIGAKIBART
异名/同义词90401
ANTI-A PROLIFERATION-INDUCING LIGAND MONOCLONAL ANTIBODY BION-1301
ANTI-APRIL MONOCLONAL ANTIBODY BION-1301
BION 1301 [WHO-DD]
BION1301
BION-1301
C90401
C-90401
IMMUNOGLOBULIN G4 (229-PROLINE), ANTI-(HUMAN PROLIFERATION-INDUCING LIGAND PROTEIN) (HUMAN-MUS MUSCULUS MONOCLONAL BION-1301 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL BION-1301 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS TNFSF13 (TUMOR NECROSIS FACTOR (TNF) SUPERFAMILY MEMBER 13, APRIL, CD256)), HUMANIZED MONOCLONAL ANTIBODY
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS TNFSF13 (TUMOR NECROSIS FACTOR (TNF) SUPERFAMILY MEMBER 13, APRIL, CD256)), HUMANIZED MONOCLONAL ANTIBODY; GAMMA4 HEAVY CHAIN HUMANIZED (1-448) (VH HUMANIZED (HOMO SAPIENS IGHV1-3*01 (83,7%) -(IGHD) -IGHJ4*01 (84,6%), CDR-IMGT (8.8.14) (26-33.51-58.97-110)) (1-121)- HOMO SAPIENS IGHG4*01, G4V5 H P10, NG4M(A) CH2 L92 (CH1 (122-219), HINGE 1-12 S10>P (229) (220-231), CH2 L92 (310) (232-341), CH3 (342-446), CHS (447-448)) (122- 448)), (135-214')-DISULFIDE WITH KAPPA LIGHT CHAIN HOMO SAPIENS (1'-214') (V-KAPPA HOMO SAPIENS IGKV1-5*01 (84%) -IGKJ2*02 (100%), CDR-IMGT (6.3.9) (27-32.50- 52.89-97)) (1'-107') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (153), V101 (191) (108'-214')); DIMER (227-227'':230- 230'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-DG44, GLYCOFORM ALFA
ZIGAKIBART
ZIGAKIBART [INN]
ZIGAKIBART [USAN]
ZIGAKIBART [WHO-DD]
ANTI-TNFSF13 MONOCLONAL ANTIBODY BION-1301
CAS登记号2642175-46-8
物质唯一标识(Unique Ingredient Identifier)WM18Z62RTI
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型 / INGREDIENT SUBSTANCE
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2026 Drugfuture->FDA Global Substance Registration System